دورية أكاديمية

52132 Real-world experience of switching atopic dermatitis treatment to upadacitinib after primary or secondary dupilumab failure.

التفاصيل البيبلوغرافية
العنوان: 52132 Real-world experience of switching atopic dermatitis treatment to upadacitinib after primary or secondary dupilumab failure.
المؤلفون: de Nicolas-Ruanes, Belen, Berna-Rico, Emilio, Garcia-Mouronte, Emilio, Azcarraga-Llobet, Carlos, Ballester-Martinez, Asuncion, Ortega-Quijano, Daniel, Segurado-Miravalles, Gonzalo, Fernandez-Nieto, Diego, Perez-Garcia, Bibiana
المصدر: Journal of the American Academy of Dermatology; 2024 Supplement, Vol. 91 Issue 3, pAB78-AB78, 1p
قاعدة البيانات: Supplemental Index
الوصف
تدمد:01909622
DOI:10.1016/j.jaad.2024.07.320